PDE5A and cirrhosis of liver: Administering the adequate dose of a PDE-5 inhibitor adjusted to the stage of liver cirrhosis the common adverse effects, such as hypotension, myalgia, back pain, headache, flushing, dyspepsia, rhinitis, and visual disturbances must be considered.